IN NONSURGICAL PATIENTS WITH HEPATOCELLULAR CANCER, WHAT TREATMENT OPTIONS EXIST, AND HOW EFFECTIVE ARE THEY?

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer in men and the eighth most common in women worldwide. Almost 600,000 new cases of HCC are diagnosed annually worldwide. Without therapy, the median length of survival is 6 months, and 5-year survival is a dismal 5%. Transplantation or resection results in the longest survival, but fewer than 20% of patients with HCC are surgical candidates. 1, 2.

Original languageEnglish (US)
Title of host publicationCurbside Consultation in GI Cancer for the Gastroenterologist
Subtitle of host publication49 Clinical Questions
PublisherCRC Press
Pages169-173
Number of pages5
ISBN (Electronic)9781040140659
ISBN (Print)9781556429842
DOIs
StatePublished - Jan 1 2024

All Science Journal Classification (ASJC) codes

  • General Medicine

Fingerprint

Dive into the research topics of 'IN NONSURGICAL PATIENTS WITH HEPATOCELLULAR CANCER, WHAT TREATMENT OPTIONS EXIST, AND HOW EFFECTIVE ARE THEY?'. Together they form a unique fingerprint.

Cite this